MK

Mohit Kumawat

Active Director Director DIN 10365464
DIN 10365464 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value •••• Premium profile

About Mohit Kumawat

Data last updated:

Mohit Kumawat is a Director at Healingways Lifesciences Private Limited (since 2023). The company operates in Pharma. Healingways Lifesciences Private Limited reported revenue of ₹8.3 Lakh (FY 2025).

DIN 10365464
Primary Designation Director
Industry Pharma
First Appointment 20 Oct 2023
Oldest Company Age 3 yrs
Largest company Healingways Lifesciences Private Limited · ₹8.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Oct 20232023₹8.3 Lakh (FY 2025)Active

Board colleagues of Mohit Kumawat

Directorship timeline

Open interactive timeline →
Healingways Lifesciences Private Limited
Premium access

Shareholding and investment profile for Mohit Kumawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohit Kumawat

Mohit Kumawat currently holds 1 directorship: Healingways Lifesciences Private Limited (Director, since 20 Oct 2023, revenue ₹8.3 Lakh (FY 2025)).

Mohit Kumawat was first appointed on 20 Oct 2023 as Director at Healingways Lifesciences Private Limited.

The current boards of Mohit Kumawat's companies include Emmanual Lawrence (Healingways Lifesciences Private Limited), Paritosh Rahi (Healingways Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available